[1] Bounda GA, Feng YU. Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds. Phcog Res. 2015;7(3):225–236.
[2] Lin L, Ni B, Lin H, Zhang M, Li X, Yin X, Qu C, Ni J. Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: A review. J Ethnopharmacol. 2015;159:158–183.
[3] Zong A, Cao H, Wang F. Anticancer polysaccharides from natural resources: a review of recent research. Carbohydr Polym. 2012;90(4):1395—–1410.
[4] Zhao J, Liang Y, Song F, Xu S, Nian L, Zhou X, Wang S. TSG attenuates LPC-induced endothelial cells inflammatory damage through notch signaling inhibition. Iubmb Life. 2016;68(1):37–50.
[5] Jiang C, Qin X, Yuan M, Lu G, Cheng Y. 2,3,5,4’-Tetrahydroxystilbene–2-O-beta-D-glucoside Reverses Stress-Induced Depression via Inflammatory and Oxidative Stress Pathways. Oxid Med Cell Longev. 2018;2018:9501427.
[6] Jiang Z, Wang W, Guo C. Tetrahydroxy stilbene glucoside ameliorates H2O2-induced human brain microvascular endothelial cell dysfunction in vitro by inhibiting oxidative stress and inflammatory responses. Mol Med Rep. 2017;16(4):5219–5224.
[7] Yao W, Huang C, Sun Q, Jing X, Wang H, Zhang W. Tetrahydroxystilbene glucoside protects against oxidized LDL-induced endothelial dysfunction via regulating vimentin cytoskeleton and its colocalization with ICAM–1 and VCAM–1. Cell Physiol Biochem. 2014;34(5):1442–1454.
[8] Wu J, Hu W, Gong Y, Wang P, Tong L, Chen X, Chen Z, Xu X, Yao W, Zhang W, Huang C. Current pharmacological developments in 2,3,4’,5-tetrahydroxystilbene 2-O-β-D-glucoside (TSG). Eur J Pharmacol. 2017;811:21–29.
[9] Yamamoto M, Clark JD, Pastor JV, Gurnani P, Nandi A, Kurosu H, Miyoshi M, Ogawa Y, Castrillon DH, Rosenblatt KP, Kuro-o M. Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem. 2005;280(45):38029–38034.
[10] Wang W, He Y, Lin P, Li P, Li Y, Sun R, Gu W, Yu J, Zhao R. In vitro effects of active components of Polygonum Multiflorum Radix on enzymes involved in the lipid metabolism. J Ethnopharmacol. 2014;153(3):763–770.
[11] Chen X, Tang K, Peng Y, Xu X. 2, 3, 4’, 5-tetrahydroxystilbene–2–0-β-D glycoside attenuates atherosclerosis in apolipoprotein E-deficient mice: role of reverse cholesterol transport. Can J Physiol Pharmacol. 2018;96(1):8–17.
[12] Zhang RY, Zhang L, Zhang L, Wang YL, Li L. Anti-amyloidgenic and neurotrophic effects of tetrahydroxystilbene glucoside on a chronic mitochondrial dysfunction rat model induced by sodium azide. J Nat Med. 2018;72(3):596–606.
[13] Jiao C, Gao F, Ou L, Yu J, Li M, Wei P, Miao F. Tetrahydroxy stilbene glycoside (TSG) antagonizes Aβ-induced hippocampal neuron injury by suppressing mitochondrial dysfunction via Nrf2-dependent HO–1 pathway. Biomed pharmacother. 2017;96:222–228.
[14] Zhang R, Sun F, Zhang L, Sun X, Li L. Tetrahydroxystilbene glucoside inhibits α-synuclein aggregation and apoptosis in A53T α-synuclein-transfected cells exposed to MPP. Can J Physiol Pharmacol. 2017;95(6):750–758.
[15] Zhang L, Huang L, Li X, Liu C, Sun X, Wu L, Li T, Yang H, Chen J. Potential molecular mechanisms mediating the protective effects of tetrahydroxystilbene glucoside on MPP-induced PC12 cell apoptosis. Mol Cell Biochem. 2017;436:203–213
[16] Mu Y, Xu Z, Zhou X, Zhang H, Yang Q, Zhang Y, Xie Y, Kang J, Li F, Wang S. 2,3,5,4’-Tetrahydroxystilbene–2-O-β-D-glucoside attenuates ischemia/reperfusion-induced brain injury in rats by promoting angiogenesis. Planta Med. 2017;83(08):676–683.
[17] Gurunath S, Nanjwade BK, Patila PA. Enhanced solubility and intestinal absorption of candesartan cilexetil solid dispersions using everted rat intestinal sacs. Saudi Pharm J. 2014;22(3):246–257.
[18] Wang X, Liu G, Yang Y, Wu X, Xu W, Yang X. Intestinal absorption of triterpenoids and flavonoids from glycyrrhizae radix et rhizoma in the human caco–2 monolayer cell model. Molecules. 2017, 22(10):1627.
[19] Artursson P, Palm K, Luthman K. Caco–2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev. 2012;64(1–2):280–289.
[20] Zhang D, Lei T, Lv C, Zhao H, Xu H, Lu J. Pharmacokinetic studies of active triterpenoid saponins and the total secondary saponin from anemone raddeana regel. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1044–1045:54–62.
[21] Xin L, Liu XH, Yang J, Shen HY, Ji G, Shi XF, Xie Y. The intestinal absorption properties of flavonoids in Hippophaë rhamnoides extracts by an in situ single-pass intestinal perfusion model. J Asian Nat Prod Res. 2019;21(1):62–75.
[22] Zhao Y, Zhang L, Feng Y, Chen D, Xi Z, Du X, Bai X, Lin R. Pharmacokinetics of 2,3,5,4′‐tetrahydroxystilbene‐2‐O‐β‐D‐glucoside in rat using ultra‐performance LC‐quadrupole TOF‐MS. J Sep Sci. 2013;36(5):863–871.
[23] Lv G, Gu H, Chen S, Lou Z, Shan L. Pharmacokinetic profile of 2,3,5,4’-tetrahydroxystilbene–2-O-β-D-glucoside in mice after oral administration of Polygonum multiflorum extract. Drug Dev Ind Pharm. 2012;38(2):248–255.
[24] Lv G, Lou Z, Chen S, Gu H, Shan L. Pharmacokinetics and tissue distribution of 2,3,5,4’-tetrahydroxystilbene–2-O-β-D-glucoside from traditional Chinese medicine Polygonum multiflorum following oral administration to rats. J Ethnopharmacol. 2011;137(1):449–456.
[25] Stappaerts J, Brouwers J, Annaert P, Augustijns P. In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities. Int J Pharm. 2015;478(2):665–681.
[26] Ayrton A, Morgan P. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica. 2001;31(8–9):469–497.
[27] Maubon N, Le Vee M, Fossati L, Audry M, Le Ferrec E, Bolze S, Fardel O. Analysis of drug transporter expression in human intestinal Caco–2 cells by real-time PCR. Fundam Clin Pharmacol. 2007;21(6):659–663.
[28] Borlak J, Zwadlo C. Expression of drug-metabolizing enzymes, nuclear transcription factors and ABC transporters in Caco–2 cells. Xenobiotica. 2003;33(9):927–943.
[29] Ahmmed SM, Mukherjee PK, Bahadur S, Harwansh RK, Kar A, Bandyopadhyay A, Al-Dhabi NA, Duraipandiyan V. CYP450 mediated inhibition potential of Swertia chirata: an herb from Indian traditional medicine. J Ethnopharmacol. 2016;178:34–39.
[30] Kapetas AJ, Sorich MJ, Rodrigues AD, Rowland A. Guidance for rifampin and midazolam dosing protocols to study intestinal and hepatic cytochrome P450 (CYP) 3A4 induction and de-induction. AAPS J. 2019;21(5):78.